Screener
Gyre Therapeutics, Inc. GYRE Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s invested capital?
- Gyre Therapeutics, Inc. (GYRE) reported invested capital of $68.06M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s invested capital changed year-over-year?
- Gyre Therapeutics, Inc.'s invested capital increased by 19.6% year-over-year, from $56.93M to $68.06M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s invested capital has grown at a -21.4% compound annual growth rate (CAGR), from $47.35M to $14.24M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Gyre Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude